000 | 00978 a2200277 4500 | ||
---|---|---|---|
005 | 20250513172526.0 | ||
264 | 0 | _c19940125 | |
008 | 199401s 0 0 eng d | ||
022 | _a0271-1206 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoyer, J G | |
245 | 0 | 0 |
_aEstablishing value through pharmacoeconomics: the emerging third objective in clinical trials. _h[electronic resource] |
260 |
_bTopics in hospital pharmacy management _cJan 1994 |
||
300 |
_a1-10 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aClinical Protocols |
650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
650 | 0 | 4 |
_aDrug Evaluation _xeconomics |
650 | 0 | 4 | _aEconomics, Pharmaceutical |
650 | 0 | 4 | _aInformed Consent |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aPathak, D S | |
773 | 0 |
_tTopics in hospital pharmacy management _gvol. 13 _gno. 4 _gp. 1-10 |
|
999 |
_c10090248 _d10090248 |